JSM 2011 Online Program
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Activity Details
|
|||
610 * ! | Thu, 8/4/2011, 8:30 AM - 10:20 AM | CC-D231/232 | |
Issues of Biomarker Testing in Clinical Trials for Personalized Medicine — Topic Contributed Papers | |||
Biopharmaceutical Section , WNAR , Scientific and Public Affairs Advisory Committee | |||
Organizer(s): Sue-Jane Wang, U.S. Food and Drug Administration/CDER | |||
Chair(s): Mingxiu Hu, Millennium: The Takeda Oncology Company | |||
8:35 AM | Testing for broad efficacy and efficacy in genomic subgroups using partitioning principle — Szu-Yu Tang, The Ohio State University ; Yi Liu, Millennium: The Takeda Oncology Company ; Jason C. Hsu, The Ohio State University | ||
8:55 AM | The Relationship Between CYP2C19 Genetic Polymorphisms, Clopidogrel Treatment, and Clinical Outcomes — Katy Simonsen, Bristol-Myers Squibb ; Oksana Mokliatchouk, Bristol-Myers Squibb ; Eileen Emison, Bristol-Myers Squibb | ||
9:15 AM | Biomarker Identification and Patient Condition Prediction Based on Gene-Expression Pattern from Two Case Studies — Yushi Liu, The Lovelace Respiratory Research Institute ; Joe Verducci, The Ohio State University | ||
9:35 AM | Model Selection v. Multiple Testing in Genome-Wide Association Studies — Florian Frommlet, Medical University Vienna ; Felix Ruhaltinger, Medical University Vienna ; Malgorzata Bogdan, TU Wroclaw | ||
9:55 AM | Exploring potential early predictors of clinical response to Yervoy immunotherapy — Scott Chasalow, Bristol-Myers Squibb ; Daniel Brickman, Bristol-Myers Squibb | ||
10:15 AM | Floor Discussion |
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.